EU adviser says Illumina merger was not problematic

Off Biotech, biotechnology, Business, CRISPR, drug development, drug prices, drug pricing, FDA, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, patients, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hi, it’s Meghana. Today, Illumina finally finds an advocate in the EU, a CRISPRed pig kidney is transplanted into a living human, and more.

Read the rest…

Read Original Article: EU adviser says Illumina merger was not problematic »

About The Author